Brown R
J Cardiovasc Dev Dis. 2024; 11(9).
PMID: 39330354
PMC: 11432391.
DOI: 10.3390/jcdd11090296.
Al-Qaisi R, Al-Gebori A, Alosami M
Indian J Clin Biochem. 2024; 39(3):401-407.
PMID: 39005859
PMC: 11239623.
DOI: 10.1007/s12291-023-01124-5.
Benkhadra M, Fituri N, Aboukhalaf S, Ghasoub R, Mattar M, Alfarsi K
Cancers (Basel). 2024; 16(11).
PMID: 38893198
PMC: 11171109.
DOI: 10.3390/cancers16112079.
Battah M, Zainal H, Ibrahim D, Md Hanafiah N, Syed Sulaiman S
PLoS One. 2024; 19(6):e0304209.
PMID: 38838036
PMC: 11152296.
DOI: 10.1371/journal.pone.0304209.
Pan S, Shen Q, Zhou J, Li T
BMC Pediatr. 2024; 24(1):209.
PMID: 38521927
PMC: 10960423.
DOI: 10.1186/s12887-024-04679-1.
Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.
Zhang Q, Zu C, Jing R, Feng Y, Zhang Y, Zhang M
Front Immunol. 2023; 14:1125357.
PMID: 37215107
PMC: 10192732.
DOI: 10.3389/fimmu.2023.1125357.
Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care.
Chapman R, Shah S, DAngelo A
J Intensive Care Soc. 2023; 24(1):112-116.
PMID: 36874287
PMC: 9975801.
DOI: 10.1177/17511437221106441.
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Li P, Liu Y, Liang Y, Bo J, Gao S, Hu Y
Cancer Biol Med. 2023; 20(2).
PMID: 36861439
PMC: 9978889.
DOI: 10.20892/j.issn.2095-3941.2022.0585.
Marine Compounds, Mitochondria, and Malignancy: A Therapeutic Nexus.
Fakhri S, Abdian S, Moradi S, Delgadillo B, Fimognari C, Bishayee A
Mar Drugs. 2022; 20(10).
PMID: 36286449
PMC: 9604966.
DOI: 10.3390/md20100625.
Pseudotyping Bacteriophage P2 Tail Fibers to Extend the Host Range for Biomedical Applications.
Cunliffe T, Parker A, Jaramillo A
ACS Synth Biol. 2022; 11(10):3207-3215.
PMID: 36084285
PMC: 9594776.
DOI: 10.1021/acssynbio.1c00629.
Efficacy of Xanthine Oxidase Inhibitors in Lowering Serum Uric Acid in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Lee Y, Hwang J, Desai S, Li X, Jenkins C, Kopp J
J Clin Med. 2022; 11(9).
PMID: 35566594
PMC: 9105680.
DOI: 10.3390/jcm11092468.
Research advances in chimeric antigen receptor-modified T-cell therapy (Review).
Luo Y, Song G, Liang S, Li F, Liu K
Exp Ther Med. 2021; 21(5):484.
PMID: 33790993
PMC: 8005741.
DOI: 10.3892/etm.2021.9915.
Steroids-has the time come to extend their use to AML?.
Farrugia M, Cutajar C, Agius J, Schembri Wismayer P
J Egypt Natl Canc Inst. 2021; 33(1):7.
PMID: 33661420
DOI: 10.1186/s43046-021-00062-8.
